Oruka Therapeutics, Inc. ORKA Unrealized Gains on Investments
Unrealized Gains on Investments at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s unrealized gains on investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s unrealized gains on investments?
- Oruka Therapeutics, Inc. (ORKA) reported unrealized gains on investments of $73K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s unrealized gains on investments changed year-over-year?
- Oruka Therapeutics, Inc.'s unrealized gains on investments increased by 82.5% year-over-year, from $40K to $73K.
- What does unrealized gains on investments mean?
- This reflects the cumulative increase in the fair market value of investment securities held by the company that have not yet been sold. It serves as an indicator of the performance of the company's treasury or investment portfolio relative to initial acquisition costs.